Physician profile
Kerry E Owens
NPI 1134128903
$1,562.51
in general payments reported to CMS, 2019-2025
11 companies · $49.17 in 2025
The $49.17 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $944 · 2020: $225 · 2021: $63.16 · 2022: $52.62 · 2023: $71.70 · 2024: $158 · 2025: $49.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $653.47 | 2019-2025 | |
| Sientra, INC. | $412.74 | 2019-2022 | |
| Revance Therapeutics, INC. | $139.00 | 2024 | Daxxify |
| Smith+Nephew, INC. | $112.73 | 2019 | |
| Stryker Corporation | $57.97 | 2023 | Spy-Phi System |
| Allergan, INC. | $57.74 | 2019-2021 | |
| Mentor Worldwide LLC | $44.67 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $29.17 | 2025 | |
| Merz North America, INC. | $22.73 | 2019 | |
| W. L. Gore & Associates, INC. | $19.03 | 2019 | |
| Bard Peripheral Vascular, INC. | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.